BVT 2733 - ≥98% , CAS No.376640-41-4

CAS: 376640-41-4 Cat. No.: B412243 Formula: C17H21ClN4O3S2 Molecular Weight: 428.96 EC Number: 808-805-6
AVAILABLE TO ORDER
GRADE & PURITY ≥98%
Synonyms
BVT.2733 | MFCD13152134 | Piperazine, 1-((2-(((3-chloro-2-methylphenyl)sulfonyl)amino)-4-thiazolyl)acetyl)-4-methyl- | EX-A2997 | NCGC00386635-01 | DTXSID00191083 | BDBM50117900 | NSC96962 | SCHEMBL368251 | 1,3-Phenylene bismalemide | BB179811 | C17H21ClN
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Size
Germany (EU)
USA*
Price
Qty
5mg
B412243-5mg
—
3 In stock

€10.33

€15.53
Save €5.21 (33.52%)
25mg
B412243-25mg
—
2 In stock

€36.36

€54.58
Save €18.22 (33.39%)
100mg
B412243-100mg
—
1 In stock

€116.19

€174.33
Save €58.14 (33.35%)
Enter a quantity for the sizes you want to add.
🧪
Why this grade

≥98% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Information

BVT 2733 BVT 2733, a new small molecule, is a non-steroidal, isoform-selective inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) .


Targets

11β-HSD1

Specifications

Synonyms
BVT.2733 | MFCD13152134 | Piperazine, 1-((2-(((3-chloro-2-methylphenyl)sulfonyl)amino)-4-thiazolyl)acetyl)-4-methyl- | EX-A2997 | NCGC00386635-01 | DTXSID00191083 | BDBM50117900 | NSC96962 | SCHEMBL368251 | 1,3-Phenylene bismalemide | BB179811 | C17H21ClN
Specifications & Purity
≥98%
Biochemical and Physiological Mechanisms
BVT 2733, a new small molecule, is a non-steroidal, isoform-selective inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1).
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type
INHIBITOR
Purity
≥98%
Names and Identifiers
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504764378
Canonical Smiles
CC1=C(C=CC=C1Cl)S(=O)(=O)NC2=NC(=CS2)CC(=O)N3CCN(CC3)C
IUPAC Name
3-chloro-2-methyl-N-[4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1,3-thiazol-2-yl]benzenesulfonamide
InChIKey
YDPRNGAPPNPYQQ-UHFFFAOYSA-N
INCHI
1S/C17H21ClN4O3S2/c1-12-14(18)4-3-5-15(12)27(24,25)20-17-19-13(11-26-17)10-16(23)22-8-6-21(2)7-9-22/h3-5,11H,6-10H2,1-2H3,(H,19,20)
Isomeric SMILES
CC1=C(C=CC=C1Cl)S(=O)(=O)NC2=NC(=CS2)CC(=O)N3CCN(CC3)C
Molecular Weight
428.96
Reaxy-Rn
9224964
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9224964&ln=

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

<<<<<<< HEAD Download SDS → ======= Download SDS → >>>>>>> release248-p3

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClassBenzene and substituted derivatives
SubclassBenzenesulfonamides
Intermediate Tree Nodes Not available
Direct ParentBenzenesulfonamides
Alternative Parents Benzenesulfonyl compounds  Toluenes  2,4-disubstituted thiazoles  N-methylpiperazines  Chlorobenzenes  Organosulfonamides  Aryl chlorides  Tertiary carboxylic acid amides  Aminosulfonyl compounds  Heteroaromatic compounds  Trialkylamines  Amino acids and derivatives  Azacyclic compounds  Carbonyl compounds  Hydrocarbon derivatives  Organic oxides  Organochlorides  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Benzenesulfonamide - Benzenesulfonyl group - 2,4-disubstituted 1,3-thiazole - Chlorobenzene - Halobenzene - N-alkylpiperazine - N-methylpiperazine - Toluene - Aryl chloride - Aryl halide - 1,4-diazinane - Piperazine - Organosulfonic acid amide - Azole - Heteroaromatic compound - Aminosulfonyl compound - Organic sulfonic acid or derivatives - Organosulfonic acid or derivatives - Sulfonyl - Tertiary carboxylic acid amide - Thiazole - Tertiary amine - Tertiary aliphatic amine - Amino acid or derivatives - Carboxamide group - Organoheterocyclic compound - Azacycle - Carboxylic acid derivative - Organohalogen compound - Amine - Organic oxide - Carbonyl group - Hydrocarbon derivative - Organic oxygen compound - Organic nitrogen compound - Organochloride - Organonitrogen compound - Organooxygen compound - Organosulfur compound - Aromatic heteromonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
HSD17B2 Tchem Estradiol 17-beta-dehydrogenase 2 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot NumberCertificate TypeDateItem
H2223060H2223060Certificate of AnalysisJun 09, 2025 B412243
H2223064H2223064Certificate of AnalysisJun 09, 2025 B412243
H2223066H2223066Certificate of AnalysisJun 09, 2025 B412243
Chemical and Physical Properties
SolubilitySolubility (25°C) In vitro DMSO: 86 mg/mL (200.48 mM); Ethanol: 3 mg/mL (6.99 mM); Water: ˂1 mg/mL
Molecular Weight429.000 g/mol
XLogP32.000
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass428.074 Da
Monoisotopic Mass428.074 Da
Topological Polar Surface Area119.000 Ų
Heavy Atom Count27
Formal Charge0
Complexity622.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No tested application protocols are provided in the Product Data for this item.

  • Item-specific recommended dilutions/assays: Not specified for this item; refer to CoA/Spec Sheet.

General research guidance (non-binding, for planning)

  • Prepare a sterile-filtered DMSO stock (e.g., 10–50 mM), aliquot, and store at −20 °C. Thaw an aliquot immediately before use and avoid repeated freeze–thaw.
  • For biochemical enzyme assays, perform serial dilutions in assay buffer to generate a concentration–response curve with appropriate vehicle controls.
  • For cell-based assays, verify cell line tolerance to vehicle (DMSO) and confirm compound solubility post-dilution (visual inspection, or analytical check).

Note: The above are generic practices and do not constitute item-specific validated protocols.

Biological Roles

Literature context (not item-specific; for research planning only)

  • BVT 2733 is widely cited as a small-molecule biochemical probe investigated for selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), a microsomal enzyme that converts inert cortisone to active cortisol using NADPH. Selective inhibition is commonly used to interrogate intracellular glucocorticoid regeneration and downstream metabolic signaling in liver, adipose, and other tissues.
  • Reported properties in the literature include:
    • High selectivity for 11β-HSD1 over 11β-HSD2 in human and rodent systems (exact IC50/Selectivity values vary by report and assay conditions). Researchers should consult primary publications and verify activity in their own hands.
    • Utility as a reference compound in enzymatic assays, pharmacology panels, and target-validation studies (in vitro and in cellulo). No medical or clinical claims are implied.

Experimental considerations

  • Stock preparation: Typically dissolved in DMSO to 10–50 mM; light and moisture sensitivity should be assessed empirically.
  • Assay notes: Enzyme assays often monitor cortisone→cortisol (or deuterated analogs) conversion via LC–MS/MS or radiometric readouts; include proper vehicle controls and, where relevant, counter-screens against 11β-HSD2.
  • Off-target profiling: For chemical probe use, it is advisable to profile against common ADME/tox panels and nucleophilic enzymes to assess selectivity.

Important: The above describes general literature use cases. This catalog item is provided strictly for research use only.

Buffer Applications

This product is not a buffering agent and does not constitute a buffer system. However, it is frequently dosed into aqueous buffers for biochemical assays.

  • Practical guidance (general; not item-specific specifications)
    • Prepare concentrated DMSO stock solutions and dilute into assay buffers such as PBS, HEPES, or Tris with a final DMSO content typically 0.05–0.5% v/v as tolerated by the biological system.
    • To mitigate precipitation, add the organic stock under vigorous mixing or after pre-diluting 1:10 in buffer.
    • For enzyme assays with 11β-HSD1 (literature context), buffers commonly include NADPH regeneration systems and a small amount of nonionic detergent (e.g., 0.01% Tween-20) to improve solubility and reduce nonspecific binding.

Note: No item-specific buffer compatibility data are provided; verify empirically for your assay.

Green Alternatives

Green solvent/reagent substitution frameworks (e.g., CHEM21, ACS GCI) are generally applied to process reagents or solvents rather than to discrete screening compounds like BVT 2733. As a target-specific probe, it has no direct “green alternative” without altering the experimental objective.

  • Practical sustainability considerations

    • Minimize solvent volumes by preparing concentrated stocks (e.g., 10–50 mM in DMSO) and aliquoting to reduce waste and freeze–thaw cycles.
    • Use microscale assays and 96–1536 well plate formats to limit chemical consumption.
    • Prefer lower-toxicity vehicles for dilutions (e.g., aqueous buffers with minimal DMSO) when biologically compatible.
    • Implement appropriate waste segregation for halogenated vs non-halogenated organic waste per institutional policy.
  • If synthetic route development to BVT 2733 is within scope (outside this catalog use)

    • Consider greener reaction media (2-MeTHF, CPME) and catalytic methods where compatible with the specific route (literature-dependent). These are general process suggestions and not specific to the supplied material.
Pharmaceutical Uses

No pharmacopeial or formulation grade information is provided for this item, and it is supplied strictly for research use only.

  • Regulatory/grade status: Not specified for this item; refer to CoA/Spec Sheet. Not intended for human or veterinary use, and not manufactured under GMP for clinical application.
  • Typical research-context uses (non-clinical)
    • Reference compound or tool molecule in preclinical enzymology and target-validation studies.
    • Method development control in LC–MS bioanalytical assays (e.g., to establish retention/ionization conditions), when appropriate and safe.

Do not use in drug product manufacturing or clinical investigations.

Physical Properties

Item-specific physicochemical specifications are not provided in the Product Data and should be confirmed on the CoA/Spec Sheet for the shipped lot.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet. (Any literature values should not be used as product specifications.)
  • Boiling point: Not applicable/relevant for a high–boiling, non-volatile solid; exact value not specified for this item.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility (practical/literature guidance — not a specification)
    • Frequently prepared as concentrated DMSO stock solutions (e.g., 10–50 mM) for biochemical or cell-based assays; dilute into aqueous buffers with ≤0.1–1% final DMSO to maintain solubility while limiting vehicle effects.
    • Limited aqueous solubility is common for hydrophobic medicinal-chemistry scaffolds; gentle sonication or warming (≤37 °C) may assist dissolution.
  • LogP/logD, pKa, refractive index: Not specified for this item; refer to CoA/Spec Sheet.

Notes

  • All numerical physical property values, if required for your method validation, must be taken from the CoA/Spec Sheet for this specific lot. Literature/computed descriptors can aid method development but do not supersede product specifications.
Quality and Grades

Item-specific grade/purity is not listed in the Product Data for this SKU and must be confirmed on the CoA/Spec Sheet.

  • Grade/purity: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/solute form: Not specified for this item; refer to CoA/Spec Sheet.

How to interpret typical quality annotations (general guidance)

  • Research grade: Suitable for discovery research, screening, and general lab use; may not include pharmaceutical GMP documentation.
  • Purity by HPLC/LC–MS: Values (if provided on CoA) indicate chromatographic purity under specified methods; they are method-dependent and do not guarantee absence of trace isomers or counter-ions.
  • Water/peroxide/metal limits, residual solvents, UV cutoff: Not specified for this item; check the CoA/SDS where applicable.
  • Solid form and salt form: Verify whether the material is free base, salt, solvate, or polymorph; this influences MW, solubility, and dosing calculations.

Recommendations

  • For quantitative biology/biochemistry, verify purity, counter-ion content, and identity (e.g., 1H NMR, HRMS) as needed for your application.
  • Record lot number and retain a copy of the CoA to ensure traceability in publications and screening databases.
Reaction and Applications

This catalog item is supplied as a finished small-molecule research compound for screening and biochemical experimentation, not as a synthetic reagent. Accordingly, it is not typically employed as a solvent, catalyst, or stoichiometric reactant in preparative organic synthesis.

  • Not typically applicable

    • Named reactions, reagent roles (e.g., reductant/oxidant, base/acid catalyst), or cross-coupling applications are not relevant to this product’s intended use.
  • Applicable uses (research context)

    • Preparation of DMSO stock solutions for in vitro enzyme assays or cell studies (research use only).
    • Reference/positive-control compound in target-based screening where literature supports its use as a chemical probe (see Biological Roles for literature context).
Reaction Conditions

Not applicable. BVT 2733 is supplied as a research compound rather than a reagent for conducting chemical reactions. There are no item-specific reaction condition recommendations.

  • If using in biological assays (general guidance)
    • Stock solvent: DMSO; typical stock 10–50 mM.
    • Working concentrations: Defined by assay design; include serial dilutions and appropriate vehicle controls.
    • Temperature: Prepare and store stocks at −20 °C; equilibrate to room temperature before opening to avoid condensation.

For any synthetic chemistry involving this scaffold (user-driven), consult the primary literature for route-specific conditions.

Safety and Handling

Safety details specific to this catalog item are not provided in the Product Data. Always consult the SDS for authoritative information.

  • GHS classification (item-specific): Not specified for this item; refer to SDS.
  • Signal word, pictograms, H-statements: Not specified for this item; refer to SDS.

General laboratory precautions (good practice for small-molecule research compounds)

  • Engineering controls: Work in a chemical fume hood to minimize inhalation exposure and to control dust/aerosols.
  • PPE: Lab coat, safety glasses or goggles, and suitable chemical-resistant gloves (e.g., nitrile). Avoid skin and eye contact; prevent ingestion and inhalation of dust or aerosols.
  • Handling: Avoid open handling of powders where possible; minimize static and use antistatic measures for microgram-to-milligram dosing. Use clean, dry tools; cap containers promptly to limit moisture/air exposure.
  • Incompatibilities: Avoid strong oxidizers and strong acids/bases unless compatibility is known. Do not mix with unknown materials.
  • First aid (overview; follow SDS/Institutional SOPs):
    • Inhalation: Move to fresh air; seek medical attention if symptoms occur.
    • Skin: Wash with soap and water; remove contaminated clothing.
    • Eyes: Rinse cautiously with water for several minutes; remove contact lenses if present and easy to do.
    • Ingestion: Rinse mouth; seek medical advice.
  • Spill/cleanup: Avoid raising dust; collect mechanically or with damp disposable wipes; dispose according to regulations.
  • Fire safety: Use CO2, dry chemical, or foam. Combustion may produce toxic fumes; firefighters should wear SCBA.

Note: For research use only; not for human or veterinary use.

Solvent Selection

This product is a drug-like small molecule typically handled as concentrated organic stock solutions for screening and biochemical assays.

  • Primary solvent (practical guidance — not a specification)
    • DMSO: Most common for initial dissolution due to high solvating power for lipophilic heteroaromatics; stable at −20 °C in aliquots. Filter if necessary (0.2 µm PTFE) to remove particulates.
  • Secondary options
    • DMF or NMP: Useful when DMSO solubility is limited, with similar handling cautions.
    • Ethanol or isopropanol: Can be used for less hydrophobic scaffolds; ensure compatibility with biological systems if used as vehicle.
  • Aqueous handling
    • Prepare a concentrated DMSO stock (e.g., 10–50 mM), then dilute into buffer/media to a final DMSO content typically 0.05–0.5% v/v (as tolerated by the system). Add stock last under vigorous mixing to minimize precipitation.
  • Miscibility/polarity (general)
    • Expected to be poorly water-soluble and highly soluble in polar aprotic solvents (DMSO/DMF). Validate empirically for your lot and assay conditions.
  • Troubleshooting
    • Precipitation after dilution: Lower final concentration, increase surfactant (e.g., 0.01–0.05% nonionic), or pre-warm buffer to 37 °C. Verify actual concentration via UV or LC–MS when feasible.

Note: No item-specific solubility or solvent specification is provided; confirm with small-scale tests before scaling experiments.

Storage and Reconstitution

Item-specific storage conditions are provided in the Product Data; reconstitution guidance below is general best practice for small-molecule research compounds.

  • Storage (from Product Data)

    • Store at −20 °C.
    • Shipped in an ice chest with ice pads to maintain cold chain.
  • Stability notes (general; verify empirically)

    • Protect from moisture and light where possible. Allow vials to warm to room temperature in a desiccator before opening to prevent condensation.
    • Once in solution (e.g., DMSO), stability can be enhanced by aliquoting under inert gas, minimizing headspace, and avoiding repeated freeze–thaw cycles.
  • Reconstitution (general guidance — not a specification)

    • Solvent: DMSO is commonly used to prepare concentrated stocks (e.g., 10–50 mM). If aqueous use is required, dilute the DMSO stock into buffer immediately before use.
    • Technique: Add a measured volume of solvent, vortex, and if necessary sonicate briefly. Filter through 0.2 µm PTFE to remove particulates for sensitive assays.
    • Working solutions: Prepare fresh on the day of use. Discard if precipitation, discoloration, or particulate formation is observed.
  • Documentation

    • Record the exact mass, final concentration, solvent lot, preparation date, and storage location. Retain CoA/SDS with the vial for traceability.

Note: For research use only.

Structure and Identity

Professional small‑molecule research compound supplied under the name BVT 2733 (CAS 376640-41-4).

  • Item-specific identifiers (from Product Data)

    • SKU: B412243
    • Product Name: BVT 2733
    • CAS: 376640-41-4
    • PubChem CID: 6918651 (literature identifier; provided in Product Data)
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet. (Note: value provided in Product Data appears incomplete.)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features (general/literature context — not item-specific)

    • BVT 2733 is widely referenced in the literature as a drug-like, heteroatom-containing small molecule used as a selective biochemical probe in enzymology studies. Specific ring systems, stereocenters, and substituent patterns vary by reported structure in different databases; consult the item’s CoA/SDS for definitive structural representation for this lot.
  • 2D structure description (general guidance)

    • As a typical medicinal-chemistry scaffold, BVT 2733 is commonly depicted as an aromatic/heteroaromatic core bearing polar heteroatoms and lipophilic substituents that confer target affinity and cell permeability (literature). Exact atom connectivity and stereochemistry must be verified from the CoA/Spec Sheet for this catalog item.
Synthetic Utility

This product is provided as a finished small-molecule probe and is not typically employed as a synthetic reagent, protecting group, catalyst, or building block.

  • Not typically applicable

    • Does not serve a defined functional role (e.g., nucleophile/electrophile precursor, ligand for catalysis) in standard synthetic methodologies.
  • If derivatization is desired (general, user-driven chemistry)

    • Researchers occasionally derivatize probe molecules to prepare biotinylated or fluorescent analogs for target engagement studies; such work requires knowledge of the exact structure and SAR to avoid loss of activity. Any modification should be guided by primary literature and verified experimentally.

Because item-specific structural details are not provided here, no further synthetic recommendations are made.

Target Specificity

No target, antigen, clone, or isotype information is provided in the Product Data for this item. This section is generally applicable to biological macromolecules (e.g., antibodies), not small-molecule compounds.

  • Item-specific target data: Not specified for this item; refer to CoA/Spec Sheet.
  • For literature background on potential biological targets studied with BVT 2733, see the Biological Roles section (research context only).

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.